The trial of the drugs, already approved for malaria, cancer and autoimmune diseases, will involve researchers at more than 600 hospitals in 52 countries.The trial of the drugs, already approved for malaria, cancer and autoimmune diseases, will involve researchers at more than 600 hospitals in 52 countries.Clinical Trials, Coronavirus (2019-nCoV), Research, Immune System, Autoimmune Diseases, World Health Organization, Tedros Adhanom GhebreyesusRead More
